Clinical Osteoporosis 2017 (CO17), hosted by the National Osteoporosis Foundation (NOF) and International Society for Clinical Densitometry (ISCD), provides the most current, clinically relevant and evidence-based information on skeletal health assessment and the prevention, diagnosis, treatment of osteoporosis.
The educational program of CO17 is designed to provide targeted opportunities for presenting the latest information in the research, prevention, diagnosis, treatment, and advances in bone densitometry and osteoporosis.
CO17 is unique in that it is the only professional meeting that encompasses all medical disciplines and specialties involved in the skeletal health assessment, diagnosis and treatment of patients with, or at risk for, osteoporosis and related fractures. The content is designed for healthcare providers with an interest in osteoporosis and skeletal assessment, including specialists and generalists working in family medicine, general and internal medicine, rheumatology, endocrinology, obstetrics/gynecology, radiology, physical and occupational therapy, and research, as well as technologists.
After completing this activity, the participant should be better able to:
1. Identify all available clinical tools used to assess fracture risk.
2. Summarize the updated osteoporosis clinical practice guidelines.
3. Cite examples of DXA best practices to performing and interpreting bone density tests.
4. Explain new and emerging treatments to reduce fracture risk.
5. Describe evidence-based guidance for reducing falls.
6. Identify clinical practice strategies for reducing the osteoporosis treatment gap.
The National Osteoporosis Foundation is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. The National Osteoporosis Foundation designates this activity for 18.25 continuing nursing education contact hours including 6.0 hours of pharmacology.
The International Society for Clinical Densitometry is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The International Society for Clinical Densitometry designates this live educational activity for a maximum of 18.25 AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in the activity.
Application has been made by the National Osteoporosis Foundation to the American Academy of Family Physicians for 22.50 Elective Credits. (Conference: 18.25 Elective Credits and FLS Symposium 4.25 Elective Credits). Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This program (conference and FLS Workshop) has been reviewed and is approved for a maximum of 22.50 AAPA Category 1 CME credits by the AAPA Review Panel.
PAs should claim only those credits actually spent participating in the CME activity.
This program was planned in accordance with AAPA CME Standards for Live Programs and for Commercial Support of Live Programs.
Application has been made to the Florida Board of Physical Therapy Practice for accreditation of this activity.
ISCD is approved by ASRT for 18.25 CE Category A credits. Participants must sign in and out each day to verify attendance and receive credit. Partial credit will not be given for either day.
A certificate of attendance will be provided on-site upon request.
In order to receive any of the credit outlined above, the participant must complete the post-activity evaluation through the mobile application or desktop version, claim credit and request their certificate.
This activity is supported by an educational grant from Amgen and Radius.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD and NOF does not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
NOF and ISCD are committed to equal opportunity and nondiscrimination in all programs and services, and do not discriminate on the basis of race/ethnicity, color, religion, sex, including marital status, national origin, ancestry, age, sexual orientation, disability, or veteran status.
Event staff will be glad to assist you with any special needs (ie, physical, dietary, etc). Please contact Teri Wiley, CME, prior to the live event at email@example.com or 757-496-0269.
NOF and ISCD shall not be held liable for personal injury, death, property damage or loss suffered by a participant in connection with any program or service, whether due to the negligence of staff or others
Requests for cancellation of meeting registration fees must be made in writing and emailed.
NOF and ISCD require instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict
of interest they may have as related to the content of this activity.
All identified conflicts of interest are thoroughly vetted by NOF and ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.
Please reference the mobile application for a full list of those individuals in control of content and their identified relevant conflict of interests.